Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SMMT | UTHR | NBIX | ||
| Company | Summit Therapeu ADR | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.50 | 367.94 | 125.18 | ||
| High | 19.44 | 374.02 | 127.00 | ||
| Low | 18.50 | 367.90 | 124.38 | ||
| Last | 19.00 | 372.89 | 125.65 | ||
| Change | +0.58 | +5.53 | +0.65 | ||
| % Change | +3.15% | +1.51% | +0.52% | ||
| Volume | 1,510,000 | 257,200 | 1,206,700 | ||
| 20-Day Average Volume | 2,058,395 | 372,005 | 1,133,195 | ||
| Previous Close | 18.42 | 367.36 | 125.00 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.94 | 377.87 | 122.35 | ||
| 20-Day Raw Stochastic | 19.92% | 39.49% | 65.36% | ||
| 20-Day Relative Strength | 47.86% | 51.82% | 55.72% | ||
| Weighted Alpha | +68.68 | +64.52 | +3.93 | ||
| Today's Opinion | 40% Buy | 80% Buy | 40% Sell | ||
| Previous Opinion | 40% Buy | 80% Buy | 40% Sell | ||
| Last Month's Opinion | 80% Buy | 64% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.77% since 11/15/24 | +2.65% since 11/15/24 | +6.99% since 11/15/24 | ||
| Low | 18.03 on 11/21/24 | 353.65 on 11/19/24 | 115.27 on 11/19/24 | ||
| High | 20.14 on 11/19/24 | 374.02 on 11/22/24 | 127.00 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | -7.72% since 10/22/24 | +0.71% since 10/22/24 | +7.60% since 10/22/24 | ||
| Low | 18.03 on 11/21/24 | 342.02 on 10/23/24 | 113.88 on 10/25/24 | ||
| High | 22.90 on 10/28/24 | 417.82 on 11/08/24 | 131.26 on 10/30/24 | ||
| 3-Month | |||||
| %Chg | +40.53% since 08/22/24 | +7.50% since 08/22/24 | -17.64% since 08/22/24 | ||
| Low | 11.76 on 09/05/24 | 337.52 on 09/13/24 | 110.95 on 10/03/24 | ||
| High | 33.89 on 09/16/24 | 417.82 on 11/08/24 | 154.87 on 08/23/24 | ||
| 6-Month | |||||
| %Chg | +332.80% since 05/22/24 | +34.89% since 05/22/24 | -9.88% since 05/22/24 | ||
| Low | 2.10 on 05/28/24 | 264.33 on 05/29/24 | 110.95 on 10/03/24 | ||
| High | 33.89 on 09/16/24 | 417.82 on 11/08/24 | 157.98 on 08/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,011,512 | 16,647,675 | 12,721,686 | ||
| Shares Outstanding, K | 737,448 | 44,645 | 101,247 | ||
| Annual Sales | 0 | 2,327,500,000 | 1,887,100,000 | ||
| Annual Net Income | -614,930,000 | 984,800,000 | 249,700,000 | ||
| Last Quarter Sales | 0 | 748,900,000 | 622,100,000 | ||
| Last Quarter Net Income | -56,250,000 | 309,100,000 | 129,800,000 | ||
| 60-Month Beta | -0.92 | 0.56 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 10/30/24 | 6.39 on 10/30/24 | 1.24 on 10/30/24 | ||
| Latest Earnings Date | 10/30/24 | 10/30/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.13 | 33.51 | ||